Related Experiment Video
Updated: Jan 21, 2026

08:48
Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
Published on: July 11, 2025
559
Tuberculosis in Poland in 2017
1National Tuberculosis and Lung Diseases Research Institute, Department of Tuberculosis Epidemiology and Surveillance
Przeglad Epidemiologiczny
|August 7, 2019
Summary
Tuberculosis incidence in Poland decreased in 2017 but remains higher than the EU/EEA average. While TB in children, HIV-positive individuals, and MDR-TB are less common, the disease disproportionately affects males and older age groups.
Area of Science:
- Epidemiology
- Public Health
- Infectious Disease Surveillance
Background:
- Tuberculosis (TB) remains a significant public health concern globally and within the European Union/European Economic Area (EU/EEA).
- Understanding the specific epidemiological features of TB in individual countries is crucial for targeted control strategies.
- Poland's TB data provides a valuable comparison point within the broader EU/EEA context.
Purpose of the Study:
- To analyze the key epidemiological characteristics of tuberculosis (TB) in Poland during 2017.
- To compare Poland's TB situation with that of other EU/EEA countries.
- To identify trends and specific demographic patterns of TB in Poland.
Main Methods:
- Analysis of national TB registry data for cases notified in 2017.
- Inclusion of drug susceptibility testing results, TB as an AIDS-defining illness data, and mortality data from the Central Statistical Office.
- Utilized European Centre for Disease Prevention and Control (ECDC) surveillance reports for comparative analysis.
Main Results:
- In 2017, Poland reported 5,787 TB cases, with an incidence rate of 15.1 per 100,000 population.
- Pulmonary TB constituted 95.6% of cases. Incidence was highest in males (22.2/100,000) and older age groups (≥65 years: 22.6/100,000).
- Multidrug-resistant TB (MDR-TB) and TB in children were less prevalent compared to EU/EEA averages.
Conclusions:
- Tuberculosis incidence in Poland showed a declining trend but exceeded the EU/EEA average in 2017.
- Males and older individuals represent key demographic groups affected by TB.
- While certain TB forms like pediatric TB and MDR-TB are less common, ongoing surveillance and targeted interventions remain essential.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
869
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
869
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis V
550
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
550
Pulmonary Tuberculosis III
959
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
959
Pulmonary Tuberculosis IV
489
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
489

